131 related articles for article (PubMed ID: 31449818)
1. Determination of the Structural Relaxation Enthalpy Using a Mathematical Approach.
Flügel K; Hennig R; Thommes M
J Pharm Sci; 2019 Nov; 108(11):3675-3683. PubMed ID: 31449818
[TBL] [Abstract][Full Text] [Related]
2. A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions, part I: a comparative analysis by thermally stimulated depolarization current and differential scanning calorimetry.
Shmeis RA; Wang Z; Krill SL
Pharm Res; 2004 Nov; 21(11):2025-30. PubMed ID: 15587924
[TBL] [Abstract][Full Text] [Related]
3. Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility.
Miller DP; Lechuga-Ballesteros D
Pharm Res; 2006 Oct; 23(10):2291-305. PubMed ID: 16955371
[TBL] [Abstract][Full Text] [Related]
4. Glass transition and enthalpy relaxation of amorphous lactose glass.
Haque MK; Kawai K; Suzuki T
Carbohydr Res; 2006 Aug; 341(11):1884-9. PubMed ID: 16709405
[TBL] [Abstract][Full Text] [Related]
5. A pragmatic test of a simple calorimetric method for determining the fragility of some amorphous pharmaceutical materials.
Hancock BC; Dalton CR; Pikal MJ; Shamblin SL
Pharm Res; 1998 May; 15(5):762-7. PubMed ID: 9619787
[TBL] [Abstract][Full Text] [Related]
6. Determination of Fragility in Organic Small Molecular Glass Forming Liquids: Comparison of Calorimetric and Spectroscopic Data and Commentary on Pharmaceutical Importance.
Chakravarty P; Pandya K; Nagapudi K
Mol Pharm; 2018 Mar; 15(3):1248-1257. PubMed ID: 29384682
[TBL] [Abstract][Full Text] [Related]
7. Nuances in the Calculation of Amorphous Solubility Enhancement Ratio.
Manchanda A; Kleppe MS; Bogner RH
J Pharm Sci; 2019 Nov; 108(11):3560-3574. PubMed ID: 31271772
[TBL] [Abstract][Full Text] [Related]
8. Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: an investigation based on a calorimetric approach.
Mao C; Chamarthy SP; Pinal R
Pharm Res; 2006 Aug; 23(8):1906-17. PubMed ID: 16858653
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of pharmaceutical amorphous solids: the study of enthalpy relaxation by isothermal microcalorimetry.
Liu J; Rigsbee DR; Stotz C; Pikal MJ
J Pharm Sci; 2002 Aug; 91(8):1853-62. PubMed ID: 12115812
[TBL] [Abstract][Full Text] [Related]
10. Commentary: Considerations in the Measurement of Glass Transition Temperatures of Pharmaceutical Amorphous Solids.
Newman A; Zografi G
AAPS PharmSciTech; 2019 Dec; 21(1):26. PubMed ID: 31848763
[TBL] [Abstract][Full Text] [Related]
11. Theoretical and experimental considerations on the enthalpic relaxation of organic glasses using differential scanning calorimetry.
Mao C; Chamarthy SP; Byrn SR; Pinal R
J Phys Chem B; 2010 Jan; 114(1):269-79. PubMed ID: 20017467
[TBL] [Abstract][Full Text] [Related]
12. A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions, part II: molecular mobility and activation thermodynamic parameters.
Shmeis RA; Wang Z; Krill SL
Pharm Res; 2004 Nov; 21(11):2031-9. PubMed ID: 15587925
[TBL] [Abstract][Full Text] [Related]
13. Estimation of the fragility index of indomethacin by DSC using the heating and cooling rate dependency of the glass transition.
Ramos JJ; Taveira-Marques R; Diogo HP
J Pharm Sci; 2004 Jun; 93(6):1503-7. PubMed ID: 15124208
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of the glass transition of an amorphous drug using modulated DSC.
Royall PG; Craig DQ; Doherty C
Pharm Res; 1998 Jul; 15(7):1117-21. PubMed ID: 9688069
[TBL] [Abstract][Full Text] [Related]
15. A fast and reliable empirical approach for estimating solubility of crystalline drugs in polymers for hot melt extrusion formulations.
Kyeremateng SO; Pudlas M; Woehrle GH
J Pharm Sci; 2014 Sep; 103(9):2847-2858. PubMed ID: 24634063
[TBL] [Abstract][Full Text] [Related]
16. Enthalpy relaxation in binary amorphous mixtures containing sucrose.
Shamblin SL; Zografi G
Pharm Res; 1998 Dec; 15(12):1828-34. PubMed ID: 9892465
[TBL] [Abstract][Full Text] [Related]
17. Vitrification of two active pharmaceutical ingredients by fast scanning calorimetry: From structural relaxation to nucleation phenomena.
Monnier X; Viel Q; Schammé B; Petit S; Delbreilh L; Dupray V; Coquerel G; Dargent E
Int J Pharm; 2018 Jan; 536(1):426-433. PubMed ID: 29225097
[TBL] [Abstract][Full Text] [Related]
18. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
[TBL] [Abstract][Full Text] [Related]
19. Calorimetric study and modeling of molecular mobility in amorphous organic pharmaceutical compounds using a modified Adam-Gibbs approach.
Mao C; Chamarthy SP; Pinal R
J Phys Chem B; 2007 Nov; 111(46):13243-52. PubMed ID: 17967007
[TBL] [Abstract][Full Text] [Related]
20. Enthalpy relaxation studies of celecoxib amorphous mixtures.
Kakumanu VK; Bansal AK
Pharm Res; 2002 Dec; 19(12):1873-8. PubMed ID: 12523668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
